About
Bioneer provides contract research and development services for biotech and pharmaceutical clients. It works on in vitro modelling, gene editing, drug formulation, recombinant proteins, and related assay development from its locations in Denmark.
Services
Cell Models & Assay Development
Develops cell models and assays for research programs.
CNS Modelling & Assay Development
Develops CNS models and assays for research and testing.
Cancer Modelling & Assays
Develops cancer models and assays for oncology research.
Gene Editing & Immune Models
Provides gene editing and immune model development services.
Drug Candidate Development & Formulation
Supports drug candidate development and formulation work.
Recombinant Protein Expression
Produces recombinant proteins through expression workflows.
Protein production
Protein Refolding
Provides protein refolding services for recombinant proteins.
Protein production
Formulation Development
Develops formulations for drug candidates and biomolecules.
22 more services
- In Vitro Modelling
- Cancer and Immuno-Oncology
- Immunology
- CNS
- Gene Editing
- Reprogramming
- Molecular Histology
- Drug Formulation
- Dynamic Gastric Model (DGM)
- Biorelevant in-vitro models
- Cellular Barrier Models
- Peptides and Proteins
- Small Molecules
- Recombinant Proteins: R&D Services
- Recombinant Proteins – Microbial
- Recombinant Proteins – Mammalian
- BioStart Package
- Manufacturing Process Development
- Manufacturing of GMP-Grade Proteins
- Non-GMP Manufacturing
- Non-GMP Manufacturing – Microbial/Mammalian
- Peptides & Proteins
Capabilities
- Assays and studies
- Small molecules
- Peptides
- Process development
- CRISPR
- In vitro models
- Cell models
14 more
- Assays
- Cancer assays
- CNS assays
- Immune models
- Molecular histology
- Cellular barrier models
- Dynamic Gastric Model
- High-density MEA assay
- Multielectrode arrays
- Assay development
- Cancer modelling
- CNS modelling
- Gene editing assays
- Biorelevant in-vitro models
- Therapeutic areas
- Cancer
- Immuno-oncology
- Immunology
- CNS
Instruments and platforms
- High-density MEA
- Multielectrode arrays
Modalities and species
- Modalities
- Small molecule
- Peptide
- Gene editing
- Recombinant protein
- Species and models
- Microbial
- Mammalian
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Industries served
- Biotech
- Pharmaceutical
Details
- Type
- CRO
- Founded
- 1982
- Based in
- Hørsholm, Denmark
Public records
- Parent company
- BIONEER A/S · DK GLEIF
- FDA establishment
- 3020925311